ConductScience.org, home

Paper23935481

Pertussis: challenges today and for the future.

Cherry JD. PLoS Pathog, 2013. Cited by 110 papers, by iCite.

Cite this record

ConductScience Library. Pertussis: challenges today and for the future. Papers, record 23935481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23935481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pertussis: challenges today and for the future.
PubMed
Journal
PLoS Pathog
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
110
iCite
Relative citation ratio, by iCite
3.82
iCite
Revised in PubMed
2021-10-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cherry JDJames D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bordetella pertussisMajor topic
Pertussis VaccineMajor topic
Whooping CoughMajor topic
Animals
Communicable Diseases, Emerging
Diphtheria-Tetanus-Pertussis Vaccine
Diphtheria-Tetanus-acellular Pertussis Vaccines
Health Transition
Humans
Pertussis Toxin
Treatment Failure
United States

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123388024Pertactin-negative variants of Bordetella pertussis in the United States.N Engl J Med2013https://conductscience.org/library/papers/23388024PubMed
219751581Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.Emerg Infect Dis2009https://conductscience.org/library/papers/19751581PubMed
415831828Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Clin Microbiol Rev2005https://conductscience.org/library/papers/15831828PubMed
526619437Characteristics of Severe Bordetella pertussis Infection Among Infants ≤90 Days of Age Admitted to Pediatric Intensive Care Units - Southern California, September 2009-June 2011.J Pediatric Infect Dis Soc2013https://conductscience.org/library/papers/26619437PubMed
614305343EFFECTIVENESS OF PERTUSSIS VACCINES.Br Med J1965https://conductscience.org/library/papers/14305343PubMed
722841154Population diversity among Bordetella pertussis isolates, United States, 1935-2009.Emerg Infect Dis2012https://conductscience.org/library/papers/22841154PubMed
822851107Number and order of whole cell pertussis vaccines in infancy and disease protection.JAMA2012https://conductscience.org/library/papers/22851107PubMed
920335431Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.Clin Vaccine Immunol2010https://conductscience.org/library/papers/20335431PubMed
1015867059The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection.Pediatrics2005https://conductscience.org/library/papers/15867059PubMed
1118558873Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.Clin Infect Dis2008https://conductscience.org/library/papers/18558873PubMed
129796041A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.Vaccine1998https://conductscience.org/library/papers/9796041PubMed
139755264The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial.Pediatrics1998https://conductscience.org/library/papers/9755264PubMed
1410585991The science and fiction of pertussis vaccines.Pediatrics1999https://conductscience.org/library/papers/10585991PubMed
1522529282Why do pertussis vaccines fail?Pediatrics2012https://conductscience.org/library/papers/22529282PubMed
1615557666Acellular pertussis vaccines and complement killing of Bordetella pertussis.Infect Immun2004https://conductscience.org/library/papers/15557666PubMed
1712897292The science and fiction of the "resurgence" of pertussis.Pediatrics2003https://conductscience.org/library/papers/12897292PubMed
1823388023Priming with whole-cell versus acellular pertussis vaccine.N Engl J Med2013https://conductscience.org/library/papers/23388023PubMed
1922894554Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease.N Engl J Med2012https://conductscience.org/library/papers/22894554PubMed
2020704492The present and future control of pertussis.Clin Infect Dis2010https://conductscience.org/library/papers/20704492PubMed
219796042Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.Vaccine1998https://conductscience.org/library/papers/9796042PubMed

Download CSV of references

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.

PMIDTitleJournalYearIn PapersSource
42550879Quantifying the impact of vaccination on pertussis dynamics in Sweden.PLoS Comput Biol2026https://conductscience.org/library/papers/42550879PubMed
41788621Hypercapnia as a Key Mechanism in the Development of Pulmonary Hypertension in Malignant Pertussis: A Case Report.Respirol Case Rep2026https://conductscience.org/library/papers/41788621PubMed
41615771
Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China.
Emerg Microbes Infect2026https://conductscience.org/library/papers/41615771PubMed
41096873Pertussis-A Re-Emerging Threat Despite Immunization: An Analysis of Vaccine Effectiveness and Antibiotic Resistance.Int J Mol Sci2025https://conductscience.org/library/papers/41096873PubMed
40278999Vaccine-Preventable Diseases in Pediatric Age Group in India: Recent Resurgence, Implications and Solutions.Indian J Pediatr2025https://conductscience.org/library/papers/40278999PubMed
39930513Epidemiological investigation of a pertussis outbreak among schoolchildren in Burkina Faso, 2019.BMC Res Notes2025https://conductscience.org/library/papers/39930513PubMed
38379743The history of pertussis: from an ancient scourge to a contemporary health burden.J Prev Med Hyg2023https://conductscience.org/library/papers/38379743PubMed
38264254Two centuries of vaccination: historical and conceptual approach and future perspectives.Front Public Health2023https://conductscience.org/library/papers/38264254PubMed
36861991Application of Traditional Vaccine Development Strategies to SARS-CoV-2.mSystems2023https://conductscience.org/library/papers/36861991PubMed
36715361Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection.Emerg Microbes Infect2023https://conductscience.org/library/papers/36715361PubMed
36016079Looking beyond Pertussis in Prolonged Cough Illness of Young Children.Vaccines (Basel)2022https://conductscience.org/library/papers/36016079PubMed
35862754Controlled Human Infection Models To Accelerate Vaccine Development.Clin Microbiol Rev2022https://conductscience.org/library/papers/35862754PubMed
35677044Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.Front Immunol2022https://conductscience.org/library/papers/35677044PubMed
35421101Dissecting recurrent waves of pertussis across the boroughs of London.PLoS Comput Biol2022https://conductscience.org/library/papers/35421101PubMed
35311902Modeling the catarrhal stage of Bordetella pertussis upper respiratory tract infections in mice.Dis Model Mech2022https://conductscience.org/library/papers/35311902PubMed
35211469Loop-Mediated Isothermal Amplification Coupled With Nanoparticle-Based Lateral Biosensor for Rapid, Sensitive, and Specific Detection of Bordetella pertussis.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/35211469PubMed
35062708Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model.Vaccines (Basel)2021https://conductscience.org/library/papers/35062708PubMed
34822547Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines.Toxins (Basel)2021https://conductscience.org/library/papers/34822547PubMed
34780046Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are.Oncol Ther2022https://conductscience.org/library/papers/34780046PubMed
34526295Pertussis seroprevalence in mother-infant pairs from India: role of maternal immunisation.Arch Dis Child2022https://conductscience.org/library/papers/34526295PubMed

See all 68 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23935481

GET https://conductscience.org/api/papers/v1/23935481/cited_by?page=2